InDevR to Develop Influenza Assay with CDC | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Life sciences assay developer InDevR is collaborating with researchers at the US Centers for Disease Control and Prevention's Influenza Division to develop a microarray assay for use in influenza virus screening.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.